Case Study

Diagnostic Cancer Study Is Rescued For On Time Premarket Approval (PMA) Filing

Source: PRA Health Sciences

Comparison of the performance of a new in vitro diagnostic test for post-colonoscopy in subjects with colorectal cancer and pre-colonoscopy in subjects from a guideline-eligible screening population.

A molecular diagnostics company with a novel in vitro diagnostic test to detect colorectal cancer requested that PRA help rescue a full-service study crucial to its premarket approval (PMA) filing. The previous CRO had missed site and patient enrollment milestones, potentially jeopardizing the study’s PMA filing and Food and Drug Admin­istration (FDA) approval.

access the Case Study!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)